Serina Therapeutics Inc. – Material Contracts Watch

EX-10.3

from 8-K 4 pages Amendment to Senior Unsecured Convertible Promissory Note

12/34/56

EX-10.2

from 8-K 20 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 27 pages Securities Purchase Agreement

12/34/56

EX-10.1

from 8-K 16 pages Senior Unsecured Convertible Promissory Note

12/34/56

EX-10.1

from 8-K 19 pages Securities Purchase Agreement

12/34/56

EX-10.41

from 424B3 11 pages Agreement

12/34/56

EX-10.41

from 10-K 12 pages Agreement

12/34/56

EX-10.1

from 8-K 13 pages Stock Purchase Agreement

12/34/56

EX-10.1

from 8-K 17 pages Serina Therapeutics, Inc. 2024 Equity Incentive Plan, as Amended

12/34/56

EX-10.3

from 10-Q 6 pages Confidential Consulting Agreement

12/34/56

EX-10.2

from 10-Q 8 pages Executive Employment Agreement

12/34/56

EX-10.1

from 8-K 8 pages Employment Agreement

12/34/56

EX-10.1

from S-8 16 pages Serina Therapeutics, Inc. 2024 Inducement Equity Plan

12/34/56

EX-10.6

from 10-Q 5 pages Allonge and Eighth Amendment to Amended and Restated Convertible Promissory Note

12/34/56

EX-10.1

from 8-K 7 pages Executive Chairman Agreement

12/34/56

EX-10.8

from 8-K 7 pages Form of Non-Qualified Stock Option Agreement

12/34/56

EX-10.6

from 8-K 13 pages Amended and Restated Serina Therapeutics, Inc. 2017 Stock Option Plan

12/34/56

EX-10.5

from 8-K 2 pages Serina Therapeutics, Inc. Director Compensation Policy

12/34/56

EX-10.4

from 8-K 14 pages Indemnification Agreement

12/34/56

EX-10.3

from 8-K 17 pages Asset Contribution Agreement

12/34/56